Depakene and c-reactive protein increased Patient Reports February 09, 2010

Depakene Side Effects Report #5309471-X
Depakene side effect was reported by a Consumer or non-health professional from FRANCE on Apr 24, 2007. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures, influenza like illness and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow failure, c-reactive protein increased, corneal neovascularisation, corneal transplant. Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL, ASPEGIC, RIVOTRIL. Patient was hospitalized and became disabled. Patient recovered.

Depakene Side Effects Report #5327039-6
Depakene side effect was reported by a Consumer or non-health professional from FRANCE on May 15, 2007. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures, influenza like illness and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow failure, c-reactive protein increased, corneal neovascularisation, corneal transplant. Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL, ASPEGIC, RIVOTRIL. Patient was hospitalized and became disabled. Patient recovered.

Depakene Side Effects Report #5191122-9
Depakene side effect was reported by a Consumer or non-health professional from FRANCE on Mar 15, 2005. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures, influenza like illness and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow failure, c-reactive protein increased, corneal neovascularisation, corneal transplant. Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL, ASPEGIC, RIVOTRIL. Patient was hospitalized and became disabled. Patient recovered.

Depakene Side Effects Report #5501438-1
Depakene side effect was reported by a Physician from FRANCE on Oct 22, 2007. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures, influenza like illness and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, back pain , blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow failure, c-reactive protein increased, cataract . Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL, ASPEGIC, RIVOTRIL. Patient was hospitalized and became disabled. Patient recovered.


Depakene Side Effects Report #5580235-5
Depakene side effect was reported by a Physician from FRANCE on Dec 27, 2007. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures, influenza like illness, epilepsy  and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, back pain , blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow failure, c-reactive protein increased, cataract . Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL, ASPEGIC, RIVOTRIL, TOPIRAMATE, LEVETIRACETAM, CLOBAZAM. Patient was hospitalized and became disabled. Patient recovered.

Depakene Side Effects Report #4625391-8
Depakene side effect was reported by a Consumer or non-health professional from on Mar 15, 2005. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow depression, c-reactive protein increased, dermatitis bullous, dermatitis exfoliative, dysphagia. Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #4661761-X
Depakene side effect was reported by a Consumer or non-health professional from on Mar 15, 2005. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow depression, c-reactive protein increased, corneal disorder, dermatitis bullous. Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #4859839-0
Depakene side effect was reported by a Consumer or non-health professional from FRANCE on Mar 15, 2005. Male patient, 20 years of age, weighting 154.3 lb, was diagnosed with partial seizures, influenza like illness and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bone marrow failure, c-reactive protein increased, corneal neovascularisation, corneal transplant. Depakene dosage: unknown. During the same period patient was treated with TRILEPTAL, ASPEGIC, RIVOTRIL. Patient was hospitalized and became disabled. Patient recovered.

Depakene Side Effects Report #5011675-0
Depakene side effect was reported by a Health Professional from FRANCE on May 15, 2006. Female patient, 29 years of age, was diagnosed with grand mal convulsion, oral contraception, prophylaxis against gastrointestinal ulcer and was treated with Depakene. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hyperglycaemia, hypertriglyceridaemia, hypoalbuminaemia, pancreatitis acute. Depakene dosage: unknown. During the same period patient was treated with LEVONORGESTREL, ZOPICLONE, BROMAZEPAM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.


Depakene Side Effects Report #4760901-1
Depakene side effect was reported by a Consumer or non-health professional from FRANCE on Aug 26, 2005. Male patient, 62 years of age, was diagnosed with epilepsy  and was treated with Depakene. After drug was administered, patient experienced the following side effects: anaemia, bicytopenia, c-reactive protein increased, leukopenia, thrombocytopenia. Depakene dosage: unknown. During the same period patient was treated with DIGOXIN, FUROSEMIDE, SOTALOL. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #4668010-7
Depakene side effect was reported by a Consumer or non-health professional from on May 10, 2005. Male patient, 57 years of age, was diagnosed with epilepsy , alcoholism  and was treated with Depakene. After drug was administered, patient experienced the following side effects: apraxia, c-reactive protein increased, cerebral atrophy, hepatic encephalopathy, hepatorenal syndrome, prothrombin time ratio decreased, pyrexia, renal failure, sepsis . Depakene dosage: unknown. During the same period patient was treated with ACAMPROSATE, VITAMINS B1 B6, DIAZEPAM, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #4678015-8
Depakene side effect was reported by a Consumer or non-health professional from on May 10, 2005. Male patient, 57 years of age, was diagnosed with epilepsy , alcoholism  and was treated with Depakene. After drug was administered, patient experienced the following side effects: apraxia, c-reactive protein increased, cerebral atrophy, hepatic encephalopathy, hepatorenal syndrome, prothrombin time ratio decreased, pyrexia, renal failure, sepsis . Depakene dosage: unknown. During the same period patient was treated with ACAMPROSATE, VITAMINS B1 B6, DIAZEPAM, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #4635783-9
Depakene side effect was reported by a Health Professional from on Mar 30, 2005. Male patient, 20 years of age, was diagnosed with epilepsy  and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, c-reactive protein increased, dermatitis bullous, dysphagia, hepatic enzyme increased, leukopenia. Depakene dosage: 500 MG, 3 IN 1 D, ORAL; 500 MG, 2 IN 1 D, ORAL. During the same period patient was treated with OXCARBAZEPINE, PHENOBARBITAL, GABAPENTIN. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #4667385-2
Depakene side effect was reported by a Consumer or non-health professional from on Mar 30, 2005. Male patient, 20 years of age, was diagnosed with epilepsy , convulsion and was treated with Depakene. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alopecia, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, c-reactive protein increased, dermatitis bullous, dysphagia, hepatic enzyme increased. Depakene dosage: unknown. During the same period patient was treated with OXCARBAZEPINE, PHENOBARBITAL, GABAPENTIN, CLONAZEPAM, LEVETIRACETAM. Patient was hospitalized. Patient recovered.


Depakene Side Effects Report #4709121-7
Depakene side effect was reported by a Consumer or non-health professional from FRANCE on June 27, 2005. Female patient was diagnosed with epilepsy  and was treated with Depakene. After drug was administered, patient experienced the following side effects: brain oedema, c-reactive protein increased, coma, hepatic failure, hypotension, shock, status epilepticus, white blood cell count increased. Depakene dosage: unknown. Patient was hospitalized. Patient died on 01/01/2005.